Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?

Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?“. Zusammen bilden sie einen einzigartigen Fingerprint.

Keyphrases

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science